A5062855002- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Cardiovascular Disease and Adiposity
- Cardiovascular Health and Disease Prevention
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Cardiovascular and exercise physiology
- Coronary Interventions and Diagnostics
- Liver Disease Diagnosis and Treatment
- Hormonal Regulation and Hypertension
- Sodium Intake and Health
- Atrial Fibrillation Management and Outcomes
- Renal and Vascular Pathologies
- Lipoproteins and Cardiovascular Health
- Cardiac Arrhythmias and Treatments
- Hemodynamic Monitoring and Therapy
- Nutritional Studies and Diet
- Cardiovascular Syncope and Autonomic Disorders
- Cerebrovascular and Carotid Artery Diseases
- Gout, Hyperuricemia, Uric Acid
- Infective Endocarditis Diagnosis and Management
- Chronic Kidney Disease and Diabetes
- Adipokines, Inflammation, and Metabolic Diseases
- Peripheral Artery Disease Management
Hippocration General Hospital
2016-2025
National and Kapodistrian University of Athens
2016-2025
Ippokrateio General Hospital of Thessaloniki
2024
Aristotle University of Thessaloniki
2024
Hellenic Air Force
2024
Frontier Science Foundation-Hellas
2017
Georgetown University
2014-2016
Georgetown University Medical Center
2014-2016
University General Hospital Attikon
2016
Diabetes Australia
2016
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
This ESH Position Paper 2021 with updated proposed recommendations was deemed necessary after the publication of a set new pivotal sham-controlled randomized clinical trials (RCTs), which provided important information about efficacy and safety endovascular device-based renal denervation (RDN) for hypertension treatment. RDN is effective in reducing or interrupting sympathetic signals to kidneys decreasing whole body activity. Five independent, fully completed, RCTs provide conclusive...
Although metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty disease, has become the most common chronic disorder, its complex pathophysiology not been fully elucidated up to date. A correlation between elevated sympathetic activation and MASLD highlighted in recent preclinical clinical studies. Furthermore, increased activity associated with main mechanisms involved MASLD, such as lipid accumulation liver, insulin resistance, dysregulation,...
Little is known regarding the clinical course and prognosis of resistant hypertension (RHT). We evaluated predictors persistent RHT associated cardiovascular risk.We studied 1911 treated hypertensive patients (aged 59±11 years, 49% men) for a mean period 3.9 years. At baseline, data were collected underwent echocardiographic measurements, routine blood testing additional workup exclusion secondary causes (office-based uncontrolled under at least three drugs including diuretic or controlled...
Acute tobacco cigarette (TC) smoking increases blood pressure and sympathetic nerve activity, whereas there are scarce data on the impact of electronic (EC) smoking. We assessed acute effects TC, EC sham pressure, heart rate nervous system. Methods: studied 12 normotensive male habitual smokers (mean age 33 years) free cardiovascular disease. The study design was randomized controlled with three experimental sessions (sham smoking, TC smoking). After baseline measurements at rest, subjects...
The beneficial cardiovascular effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors irrespective the presence diabetes mellitus are nowadays well established and they already constitute a significant pillar for management heart failure, ejection fraction. exact underlying mechanisms accountable these effects, however, remain largely unknown. direct effect on endothelial function microcirculation is one most studied. broad range studies presented in this review aims to link all...
AimsIn this study, we investigated the combined effect of increased high-sensitivity C-reactive protein (hs-C-reactive protein) and hypoadiponectinaemia on aortic stiffness in essential hypertensive subjects.
Although obstructive sleep apnoea syndrome (OSAS) is accompanied by an increased atherosclerotic cardiovascular disease burden, its relationship with arterial stiffness not yet well determined. We investigated whether essential hypertensive individuals OSAS are characterized stiffness.Our study population consisted of 46 consecutive patients newly diagnosed untreated stage I-II hypertension suffering from (35 men, aged 49 +/- 8 years) and 53 without OSAS, matched for age, sex, smoking...
This ESH update was deemed necessary with the publication of new results sham-controlled randomized blinded prospective trials renal denervation (RDN). Proof concept studies and first (some were sham-controlled) displayed discrepant about efficacy RDN. Three 2.0 generation yielded now similarity in average blood pressure decrease following Reduction ambulatory approximately 5 to 7 mmHg office 10 mmHg. Such a by pharmacologic therapy has been found be associated lower incidence cardiovascular...